Aavatar Therapeutics

BiotechnologySeries BHanam, South Koreaaavatartps.com

Latest round

Series B

Last raised

Sep 2026

Total raised

$7.4M

Investors

5

About Aavatar Therapeutics

Founded in 2020 and based in Gyeonggi-do, South Korea, Aavatar Therapeutics Inc. operates as a biotechnology company that develops nanoparticle-based products as agents to treat genetic diseases. In September 2026, Aavatar Therapeutics Inc. The firm develops and offers a gene therapy platform based on artificial intelligence (AI) and deep learning that provides individual diagnoses based on their disease and offers gene therapy products created using nanoparticles to offer therapies. The company creates drugs using capsid engineering and promoter engineering technologies. HB Investment backed the company based on its next-generation capsid engineering technology and experienced gene therapy development team.

Who invested in Aavatar Therapeutics

5 investors across 2 rounds

See all investors in Aavatar Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Sep 29, 2026

    Amount

    $3.6M

    Investors

    Locked

  2. Series A

    Nov 7, 2023

    Amount

    $3.8M

    Investors

    Locked

Questions about Aavatar Therapeutics

Who invested in Aavatar Therapeutics?

Aavatar Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Aavatar Therapeutics raised?

Aavatar Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Aavatar Therapeutics last raise money?

Aavatar Therapeutics's most recent round on record is a Series B, in Sep 2026.

What does Aavatar Therapeutics do?

Founded in 2020 and based in Gyeonggi-do, South Korea, Aavatar Therapeutics Inc.

Where is Aavatar Therapeutics headquartered?

Aavatar Therapeutics is headquartered in Hanam, South Korea.

Which VCs invest in companies like Aavatar Therapeutics?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Aavatar Therapeutics's stage. Their profiles are linked below.

Raising like Aavatar Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.